Listed

Jones Hill Capital LP

An institutional investment manager in NEW YORK, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 13, 2026. SEC CIK 2102314.

Share

Share this page

Story card, 1080 × 1920

Holdings: 29 positions

The filing on sec.gov

As filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.

IssuerClassCUSIPReported value$mWeightSharesPut or callChange on the quarter before
Biomarin Pharmaceutical IncBMRNCOM09061G10181.917.4%1,431,590Added+163,200
Gilead Sciences IncGILDCOM37555810343.39.2%343,043New+343,043
Arcutis Biotherapeutics IncARQTCOM03969K10828.66.1%1,089,701New+1,089,701
Madrigal Pharmaceuticals IncMDGLCOM55886810528.26.0%52,545New+52,545
Bicara Therapeutics IncBCAXCOM05547710326.55.6%892,621Reduced−367,515
Relmada Therapeutics IncRLMDCOM75955J40225.35.4%3,655,075Added+3,312,323
Trevi Therapeutics IncTRVICOM89532M10125.05.3%1,339,212Added+969,037
Pharvaris N VCOMN6960510823.45.0%677,879Added+510,865
Xenon Pharmaceuticals IncXENECOM98420N10522.24.7%367,900New+367,900
ANI Pharmaceuticals IncANIPCOM00182C10319.44.1%233,808Reduced−84,783
Immunocore Holdings plcIMCRADS45258D10516.33.5%512,856New+512,856
Amylyx Pharmaceuticals IncAMLXCOM03237H10116.13.4%894,058Reduced−704,736
Insmed IncINSMCOM PAR $.0145766930713.02.8%122,375New+122,375
Nuvalent IncCOM67070310712.22.6%98,442Reduced−202,388
Capricor Therapeutics IncCAPRCOM NEW14070B30910.12.2%420,751Reduced−488,456
Aclaris Therapeutics IncACRSCOM00461U1059.32.0%1,759,492New+1,759,492
Immunic IncIMUXCOM NEW4525EP2008.31.8%539,814New+539,814
Oric Pharmaceuticals IncORICCOM68622P1098.11.7%747,313New+747,313
Tonix Pharmaceuticals HLDG CTNXPCOM NEW8902608398.01.7%625,428Added+173,312
Syndax Pharmaceuticals IncSNDXCOM87164F1057.41.6%340,000New+340,000
Olema Pharmaceuticals IncOLMACOM68062P1067.21.5%574,166New+574,166
VIR Biotechnology IncVIRCOM92764N1026.71.4%659,213Reduced−539,000
Corbus Pharmaceuticals HoldingsCRBPCOM NEW21833P3016.11.3%653,572New+653,572
Dianthus Therapeutics IncDNTHCOM2528281085.61.2%57,100New+57,100
Vertex Pharmaceuticals IncVRTXCOM92532F1005.51.2%11,123Reduced−97,480
Enliven Therapeutics IncELVNCOM29337E1022.50.5%49,850Reduced−543,190
Structure Therapeutics IncGPCRSPONSORED ADS86366E1062.20.5%40,567Reduced−60,026
Phathom Pharmaceuticals IncPHATCOM71722W1071.80.4%161,486New+161,486
Achieve Life Science IncACHVCOM0044685000.2<0.1%26,760New+26,760

Sold out: 12 positions

Held at the end of the quarter before and not reported this quarter.

IssuerClassCUSIPReported value$WeightSharesPut or callChange on the quarter before
Argenx SEARGXSPONSORED ADR04016X1010.00.0%0Sold out−25,995
Arrivent Biopharma IncAVBPCOM04272N1020.00.0%0Sold out−45,809
Contineum Therapeutics IncCTNMCL A21217B1000.00.0%0Sold out−513,053
Entrada Therapeutics IncTRDACOM29384C1080.00.0%0Sold out−374,010
Fulcrum Therapeutics IncFULCCOM3596161090.00.0%0Sold out−1,771,926
Nuvation Bio IncNUVBCOM CL A67080N1010.00.0%0Sold out−2,383,031
Oruka Therapeutics IncORKACOM6876041080.00.0%0Sold out−140,843
Silence Therapeutics plcSLNADS82686Q1010.00.0%0Sold out−301,604
Terns Pharmaceuticals IncCOM8808811070.00.0%0Sold out−521,237
Ultragenyx Pharmaceutical inRARECOM90400D1080.00.0%0Sold out−1,165,557
Vaxcyte IncPCVXCOM92243G1080.00.0%0Sold out−644,831
Veradermics IncMANECOMMON STOCK9229671040.00.0%0Sold out−100,843

Source: SEC EDGAR, Form 13F-HR, accession 0002102314-26-000005 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.